TipRanks
Advertisement
Advertisement

DE:26CA Stock Latest News

ImmunityBio rises 12.3%
The FlyImmunityBio rises 12.3%
1d ago
IBRX
ImmunityBio call volume above normal and directionally bullish
PremiumThe Fly
ImmunityBio call volume above normal and directionally bullish
9d ago
IBRX
ImmunityBio put volume heavy and directionally bearish
PremiumThe Fly
ImmunityBio put volume heavy and directionally bearish
22d ago
IBRX
Unusually active option classes on open August 10th
PremiumThe Fly
Unusually active option classes on open August 10th
2M ago
B
COO
ImmunityBio appoints Kim as Vice Chairman
PremiumThe Fly
ImmunityBio appoints Kim as Vice Chairman
2M ago
IBRX
BTIG’s Mukherjee Reiterates Buy on ImmunityBio as ANKTIVA Growth, Upcoming QUILT-2.005 Milestones Support Unchanged $12 Price Target
PremiumRatingsBTIG’s Mukherjee Reiterates Buy on ImmunityBio as ANKTIVA Growth, Upcoming QUILT-2.005 Milestones Support Unchanged $12 Price Target
2M ago
IBRX
ImmunityBio: ANKTIVA’s Sustained Growth and Regulatory Catalysts Support Reaffirmed Buy Rating and Unchanged $15 Price Target
Premium
Ratings
ImmunityBio: ANKTIVA’s Sustained Growth and Regulatory Catalysts Support Reaffirmed Buy Rating and Unchanged $15 Price Target
2M ago
IBRX
ImmunityBio reports Q2 EPS (22c) vs. (10c) last year
Premium
The Fly
ImmunityBio reports Q2 EPS (22c) vs. (10c) last year
2M ago
IBRX
ImmunityBio wins UAE approval for ANKTIVA cancer therapies
PremiumCompany Announcements
ImmunityBio wins UAE approval for ANKTIVA cancer therapies
2M ago
8K
IBRX
Unusually active option classes on open June 29th
PremiumThe Fly
Unusually active option classes on open June 29th
3M ago
BE
WEN
ImmunityBio Shareholders Reelect Board at 2026 Annual Meeting
PremiumCompany Announcements
ImmunityBio Shareholders Reelect Board at 2026 Annual Meeting
4M ago
8K
IBRX
Midday Fly By: Estee Lauder walks from Puig, Imax reportedly explores sale
PremiumThe Fly
Midday Fly By: Estee Lauder walks from Puig, Imax reportedly explores sale
4M ago
BJ
EL
ImmunityBio highlights patient survey data on NMIBC at ISPOR 2026
PremiumThe FlyImmunityBio highlights patient survey data on NMIBC at ISPOR 2026
4M ago
IBRX
ImmunityBio presents health economic analysis on ANKTIVA plus BCG
Premium
The Fly
ImmunityBio presents health economic analysis on ANKTIVA plus BCG
4M ago
IBRX
Midday Fly By: Target, Lowe’s, TJX report Q1 beats
Premium
The Fly
Midday Fly By: Target, Lowe’s, TJX report Q1 beats
4M ago
BA
BZ
ImmunityBio announces FDA acceptance of supplemental BLA for ANKTIVA
PremiumThe Fly
ImmunityBio announces FDA acceptance of supplemental BLA for ANKTIVA
4M ago
IBRX
ImmunityBio announces results from ITC analyses of NAI with BCG
PremiumThe Fly
ImmunityBio announces results from ITC analyses of NAI with BCG
5M ago
IBRX
ImmunityBio Secures Exclusive Tokyo-172 BCG Rights in U.S.
PremiumCompany Announcements
ImmunityBio Secures Exclusive Tokyo-172 BCG Rights in U.S.
5M ago
8K
IBRX
ImmunityBio announces five U.S. patents issued for Anktiva with BCG
PremiumThe Fly
ImmunityBio announces five U.S. patents issued for Anktiva with BCG
5M ago
IBRX
ImmunityBio signs exclusive U.S. agreement with Japan BCG Laboratory
PremiumThe FlyImmunityBio signs exclusive U.S. agreement with Japan BCG Laboratory
5M ago
IBRX
ImmunityBio price target lowered to $12 from $13 at BTIG
Premium
The Fly
ImmunityBio price target lowered to $12 from $13 at BTIG
5M ago
IBRX
ImmunityBio reports Q1 EPS (62c) vs (15c) last year
Premium
The Fly
ImmunityBio reports Q1 EPS (62c) vs (15c) last year
5M ago
IBRX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >